首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.
【2h】

Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.

机译:福莫特罗和沙丁胺醇抑制豚鼠中缓激肽和组胺引起的气道微血管渗漏。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The effects of the beta 2-adrenoceptor agonists, salbutamol and formoterol, on the increase of microvascular permeability induced by histamine or bradykinin in guinea-pig airways have been studied in vivo. Extravasation of intravenously injected Evans blue dye was used as an index of permeability. The effects of salbutamol and formoterol on the increase in pulmonary airway resistance induced by histamine or bradykinin have also been studied. 2. The increase in pulmonary airway resistance induced by histamine or bradykinin was totally inhibited by salbutamol and formoterol. The ED50 of the two mediators were 0.59 +/- 0.21 (n = 5) and 0.20 +/- 0.14 (n = 5) micrograms kg-1 respectively for salbutamol, and 0.13 +/- 0.12 (n = 6) and 0.02 +/- 0.01 (n = 6) micrograms kg-1 respectively for formoterol. 3. Salbutamol (10 and 30 micrograms kg-1) and formoterol (1 and 10 micrograms kg-1) inhibited the increase of microvascular permeability induced by histamine (30 micrograms kg-1) in the guinea-pig airways. The inhibitory effect was predominant in the trachea and the main bronchi, with a maximum inhibition of 20 to 50%. The two drugs had little or no inhibitory effect on the other structures studied, viz. nasal mucosa, larynx, proximal and distal intrapulmonary airways. 4. Salbutamol and formoterol (1 and 10 micrograms kg-1) abolished the increase in microvascular permeability induced by bradykinin (0.3 micrograms kg-1). This inhibitory effect of two beta-adrenoceptor stimulants was predominant in the trachea and the nasal mucosa where it was observed with 1 microgram kg-1 of the beta-adrenoceptor agonists.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.已在体内研究了β2肾上腺素受体激动剂沙丁胺醇和福莫特罗对组胺或缓激肽诱导的豚鼠气道微血管通透性增加的影响。静脉注射伊文思蓝染料的外渗被用作渗透性的指标。还研究了沙丁胺醇和福莫特罗对组胺或缓激肽诱导的肺气道阻力增加的影响。 2.沙丁胺醇和福莫特罗完全抑制了由组胺或缓激肽引起的肺气道阻力的增加。沙丁胺醇的两种介质的ED50分别为0.59 +/- 0.21(n = 5)和0.20 +/- 0.14(n = 5)微克kg-1,以及0.13 +/- 0.12(n = 6)和0.02 +福莫特罗分别为0.01(n = 6)微克kg-1。 3.沙丁胺醇(10和30微克kg-1)和福莫特罗(1和10微克kg-1)抑制了豚鼠呼吸道中组胺(30微克kg-1)诱导的微血管通透性增加。在气管和主要支气管中主要是抑制作用,最大抑制作用为20%至50%。两种药物对所研究的其他结构几乎没有抑制作用,即没有抑制作用。鼻粘膜,喉,近端和远端肺内气道。 4.沙丁胺醇和福莫特罗(1和10微克kg-1)消除了缓激肽(0.3微克kg-1)引起的微血管通透性增加。这两种β-肾上腺素受体兴奋剂的这种抑制作用在气管和鼻粘膜中占主导地位,使用1微克kg-1的β-肾上腺素受体激动剂即可观察到。(摘要摘录于250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号